Home
Conditions
Multiple Myeloma and Plasma Cell Neoplasm

Clinical trial condition

Multiple Myeloma and Plasma Cell Neoplasm

Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.

214 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma and Plasma Cell Neoplasm trial results

Completed

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

NCT00002657

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations: MBCCOP - University of South Alabama Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 86 locations

View Trial Details

Completed

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

NCT00005805

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

NCT00089167

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00027560

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

NCT00003853

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

University of Pavia Pavia, Italy

View Trial Details

Completed

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

NCT00900406

Conditions: Adnexal Diseases, Blood Protein Disorders, Bone Marrow Diseases, +58 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

NCT00255749

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +64 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NCT00296023

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions: Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Boston Medical Center Boston, Massachusetts, United States

Algemeen Ziekenhuis Middelheim Antwerp, Belgium

Hopital Universitaire Erasme Brussels, Belgium

View all 28 locations

View Trial Details

Multiple Myeloma and Plasma Cell Neoplasm

Multiple Myeloma and Plasma Cell Neoplasm trial results

Related conditions